tirzepatide pregnancy discontinue before conception how long and GLP-1s (Weight loss injections) AND

Clinical studies have demonstrated significant weight loss outcomes with Tirzepatide, showing an average weight loss of 12% over a 68-week period

Who should take Tirzepatide treatment for weight loss

Tirzepatide vs Dulaglutide in Type 2 Diabetes The SURPASS-CVOT trial compared tirzepatide and dulaglutide in over 13,000 patients with type 2 diabetes and cardiovascular disease

Many insurance plans require prior authorization and documentation of previous weight management attempts

Study participants had a mean baseline body weight of 222lbs or 100.7kgs) and baseline A1C of 8.0%

Patients had a mean age of 15 years, and 61% were female